EVALUATION OF CURRENTLY USED MEDICATIONS FOR COVID-19 MANAGEMENT
Critical Care Medicine
; 50:116-116, 2022.
Article
in English
| Academic Search Complete | ID: covidwho-1594812
ABSTRACT
B Introduction:
b The COVID-19 pandemic remains an immediate and present concern, yet as of now there is still ongoing controversial discussions about the available therapeutics for the treatment of COVID-19. BMethod:
b A retrospective cohort study was conducted among all COVID-19 patients in the Intensive Care Unit (ICU) of Asir Central Hospital in Saudi Arabia between the 1 SP st sp and 30 SP th sp of June 2020. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
Full text:
Available
Collection:
Databases of international organizations
Database:
Academic Search Complete
Type of study:
Experimental Studies
Language:
English
Journal:
Critical Care Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS